Cutting edge:: In contrast to effector T cells, CD4+CD25+ FoxP3+ regulatory T cells are highly susceptible to CD95 ligand- but not to TCR-mediated cell death

被引:152
作者
Fritzsching, B
Oberle, N
Eberhardt, N
Quick, S
Haas, J
Wildemann, B
Krammer, PH
Suri-Payer, E
机构
[1] German Canc Res Ctr, Tumor Immunol Program D030, D-69120 Heidelberg, Germany
[2] Heidelberg Univ, Dept Neurol, Div Mol Neuroimmunol, Heidelberg, Germany
关键词
D O I
10.4049/jimmunol.175.1.32
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD4(+) CD25(+) FoxP3(+) regulatory T cells (T-reg) suppress T cell function and protect rodents from autoimmune disease. Regulation of T-reg during an immune response is of major importance. Enhanced survival of T-reg is beneficial inautoimmunedisease, where as increased depletion by apoptosis is advantageous in cancer. We show here that freshly isolated FACS-sorted T-reg are highly sensitive toward CD95-mediated apoptosis, whereas other T cell populations are resistant to CD95-induced apoptosis shortly after isolation. In contrast, TCR restimulation of T-reg in vitro reg revealed a reduced sensitivity toward activation-induced cell death compared with CD4(+) CD25(-)T cells. Thus, the apoptosis phenotype of T is unique in comparison to reg other T cells, and this might be further explored for novel therapeutic modulations of Treg.
引用
收藏
页码:32 / 36
页数:5
相关论文
共 28 条
  • [1] ORGAN-SPECIFIC AUTOIMMUNITY
    BACH, JF
    [J]. IMMUNOLOGY TODAY, 1995, 16 (07): : 353 - 355
  • [2] Modulation of Fas-dependent apoptosis: A dynamic process controlling both the persistence and death of CD4 regulatory T cells and effector T cells
    Banz, A
    Pontoux, C
    Papiernik, M
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 169 (02) : 750 - 757
  • [3] CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity
    Belkaid, Y
    Piccirillo, CA
    Mendez, S
    Shevach, EM
    Sacks, DL
    [J]. NATURE, 2002, 420 (6915) : 502 - 507
  • [4] Differential response of murine CD4+CD25+ and CD4+CD25- T cells to dexamethasone-induced cell death
    Chen, X
    Murakami, T
    Oppenheim, JJ
    Howard, DMZ
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2004, 34 (03) : 859 - 869
  • [5] Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
    Curiel, TJ
    Coukos, G
    Zou, LH
    Alvarez, X
    Cheng, P
    Mottram, P
    Evdemon-Hogan, M
    Conejo-Garcia, JR
    Zhang, L
    Burow, M
    Zhu, Y
    Wei, S
    Kryczek, I
    Daniel, B
    Gordon, A
    Myers, L
    Lackner, A
    Disis, ML
    Knutson, KL
    Chen, LP
    Zou, WP
    [J]. NATURE MEDICINE, 2004, 10 (09) : 942 - 949
  • [6] CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation
    Edinger, M
    Hoffmann, P
    Ermann, J
    Drago, K
    Fathman, CG
    Strober, S
    Negrin, RS
    [J]. NATURE MEDICINE, 2003, 9 (09) : 1144 - 1150
  • [7] Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFα therapy
    Ehrenstein, MR
    Evans, JG
    Singh, A
    Moore, S
    Warnes, G
    Isenberg, DA
    Mauri, C
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 200 (03) : 277 - 285
  • [8] CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative
    Ghiringhelli, F
    Larmonier, N
    Schmitt, E
    Parcellier, A
    Cathelin, D
    Garrido, C
    Chauffert, B
    Solary, E
    Bonnotte, B
    Martin, F
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2004, 34 (02) : 336 - 344
  • [9] Activation-induced cell death in T cells
    Green, DR
    Droin, N
    Pinkoski, M
    [J]. IMMUNOLOGICAL REVIEWS, 2003, 193 (01) : 70 - 81
  • [10] Superantigen-induced regulatory T cells display different suppressive functions in the presence or absence of natural CD4+CD25+ regulatory T cells in vivo
    Grundström, S
    Cederbom, L
    Sundstedt, A
    Scheipers, P
    Ivars, F
    [J]. JOURNAL OF IMMUNOLOGY, 2003, 170 (10) : 5008 - 5017